2018 | | Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia | 황교승 |
2016 | | Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong) | 박진선, 신준한 |
2022 | | Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial | 신준한 |
2020 | | Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia | 신준한 |
2021 | | Efficacy and safety of nebivolol in Korean patients with hypertension by age and sex: a subanalysis from the BENEFIT-KOREA study | 임홍석 |
2023 | | Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial | 최소연 |
2016 | | Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial | 신준한 |
2012 | | Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies | 신준한 |
2019 | | Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study | 윤명호 |
2017 | | Efficacy and tolerability of two different formulations of atorvastatin in Korean patients with hypercholesterolemia: a multicenter, prospective, randomized clinical trial | 탁승제 |
2012 | | Efficacy of clotinab in acute myocardial infarction trial-ST elevation myocardial infarction (ECLAT-STEMI) | 탁승제 |
2014 | | Efficacy of combination treatment with intracoronary abciximab and aspiration thrombectomy on myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary coronary stenting. | 탁승제 |
2015 | | Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy. | 신준한 |
2005 | | Efficacy of myocardial contrast echocardiography in the diagnosis and risk stratification of acute coronary syndrome. | 강수진 |
2022 | | Electrocardiographic biomarker based on machine learning for detecting overt hyperthyroidism | 박래웅, 소문승, 전자영, 진우람 |
2003 | | Endothelial dysfunction and alteration of nitric oxide/ cyclic GMP pathway in patients with exercise-induced hypertension. | 신준한, 윤명호, 장혁재, 최병일, 최병주, 최소연, 최태영, 탁승제, 황교승 |
2004 | | Endothelial dysfunction in patients with exaggerated blood pressure response during treadmill test. | 신준한, 윤명호, 최소연, 탁승제, 황교승 |
2013 | | Epicardial adipose tissue thickness is a predictor for plaque vulnerability in patients with significant coronary artery disease. | 박진선, 신준한, 양형모, 윤명호, 임홍석, 최병주, 최소연, 탁승제, 황교승 |
2022 | | Epicardial Adipose Tissue Thickness Is Related to Plaque Composition in Coronary Artery Disease | 박범희, 박진선, 서경우, 신준한, 양형모, 윤명호, 임홍석, 진우람, 최병주, 최소연 |
2015 | | Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients. | 양형모 |